Wilson’s disease is inherited in an autosomal recessive pattern, meaning a child must receive a faulty copy of the responsible gene from both parents to develop the condition. If both parents are carriers, each pregnancy carries a 25% chance of producing an affected child, a 50% chance of producing another carrier, and a 25% chance of producing a child with two normal copies. Most parents of a child with Wilson’s disease have no symptoms themselves and often have no idea they carry the gene.
The Gene Behind Wilson’s Disease
Wilson’s disease traces to changes in a single gene called ATP7B, located on chromosome 13. This gene provides instructions for building a protein that acts as a copper transporter inside liver cells. Under normal circumstances, this protein does two essential jobs: it loads copper onto a carrier molecule in the blood so copper can reach the rest of the body, and it shuttles excess copper into bile so the body can eliminate what it doesn’t need.
When both copies of ATP7B carry harmful variants, neither copy can produce a functional transporter. Copper has no reliable exit route from the liver. It accumulates there first, eventually spilling into the bloodstream and depositing in the brain, eyes, kidneys, and other organs. The disease doesn’t stem from absorbing too much copper from food. It stems from an inability to get rid of a normal amount.
What “Autosomal Recessive” Means in Practice
Humans carry two copies of nearly every gene, one inherited from each parent. “Autosomal” means the ATP7B gene sits on a non-sex chromosome, so Wilson’s disease affects males and females equally. “Recessive” means one working copy of the gene is enough to handle copper transport adequately. A person with one normal copy and one faulty copy is a carrier: healthy, with no copper buildup, but capable of passing the variant to their children.
The math works out simply when both parents are carriers. For each pregnancy:
- 25% chance the child inherits two faulty copies and develops Wilson’s disease
- 50% chance the child inherits one faulty copy and becomes a carrier like the parents
- 25% chance the child inherits two normal copies
These odds reset with every pregnancy. Having one affected child doesn’t reduce the risk for the next. And because carriers show no signs, the disease often appears to strike without warning in families with no known history.
How Common Are Carriers?
Wilson’s disease is rare but not as rare as once thought. A large meta-analysis of genetic data estimated the prevalence at roughly 1 in 7,200 people, which is significantly higher than the older clinical estimate of about 1 in 30,000. The gap exists because many cases go undiagnosed or are misdiagnosed as other liver or neurological conditions.
Working backward from that prevalence using recessive inheritance math, roughly 1 in 42 people carry a single faulty copy of ATP7B. That’s common enough that two carriers meeting and having children together is far from extraordinary, even without any family connection to the disease.
Why Family Screening Matters
Because Wilson’s disease is recessive, a diagnosis in one family member has immediate implications for siblings. If both parents are confirmed carriers, every sibling of an affected person has a 25% chance of also having the disease, even if they feel perfectly fine. Copper accumulation is gradual, and symptoms sometimes don’t appear until the teens or twenties. By that point, organ damage may already be underway.
The Mayo Clinic recommends that all siblings and children of someone diagnosed with Wilson’s disease undergo genetic testing. Identifying the condition before symptoms start allows treatment to begin early, which can prevent liver damage, neurological problems, and psychiatric symptoms entirely. This is one of the clearest examples in medicine where a genetic diagnosis in one person can directly protect relatives.
Genetic Testing and Diagnosis
Diagnosing Wilson’s disease has traditionally relied on a combination of blood tests, urine copper levels, eye exams looking for copper rings in the cornea, and sometimes liver biopsy. A clinical scoring system called the Leipzig score pulls these results together, with a score of 4 or higher considered diagnostic.
Genetic testing adds a powerful layer of confirmation. In a prospective study, genetic analysis confirmed the diagnosis in 90% of patients tested. More strikingly, 38% of those genetically confirmed cases had initially scored below the diagnostic threshold on clinical testing alone. Some patients with scores as low as 1, well below the usual cutoff, turned out to have Wilson’s disease when their DNA was examined. This means relying solely on blood work and clinical signs misses a meaningful number of cases, particularly in people with subtle or atypical presentations.
For family screening, genetic testing is especially useful. Once the specific ATP7B variants in an affected person are identified, testing siblings for those exact variants is straightforward and definitive. It can distinguish between a sibling who is unaffected, a carrier, or someone with two faulty copies who hasn’t yet developed symptoms.
Can You Develop Wilson’s Disease Without Family History?
Yes, and most people diagnosed have no known family history. This is a hallmark of recessive conditions. Carriers are healthy and have no reason to suspect they carry the gene. The variant can pass silently through generations, with carriers having children with non-carriers and never producing an affected child. It only becomes visible when two carriers happen to have a child together and that child inherits both faulty copies.
This is also why Wilson’s disease is more common in populations with higher rates of consanguinity (marriage between relatives), where the chance of both parents carrying the same rare variant increases. But it occurs across all ethnic groups and geographic regions.